BridgeBio Oncology Therapeutics Inc. (BBOT) Stock Price History
Historical prices from 2024 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
BBOT Stock Price Trajectory (2024–2026)
As of March 1, 2026, BridgeBio Oncology Therapeutics Inc. (BBOT) trades at $10.03, representing a -9.2% return over the past year. The stock has delivered a -0.3% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $14.87 on December 8, 2025. From this peak, BBOT has corrected -32.5%, currently trading 11% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers RVMD (+150.4% 1Y), INCY (+37.8% 1Y), and GMAB (+29.8% 1Y), BBOT has underperformed the peer group average. Compare BBOT vs RVMD →
Historical Price Data
Showing 30 of 515 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 10.25 | 10.38 | 9.95 | 10.03 | 10 | -2.15% |
| 2026-02-26 | 10.28 | 10.41 | 9.90 | 10.25 | 10 | -0.49% |
| 2026-02-25 | 10.32 | 10.56 | 10.17 | 10.30 | 10 | -0.19% |
| 2026-02-24 | 10.22 | 10.49 | 10.10 | 10.32 | 10 | +1.67% |
| 2026-02-23 | 9.97 | 10.27 | 9.86 | 10.15 | 10 | +1.70% |
| 2026-02-20 | 10.00 | 10.12 | 9.82 | 9.98 | 9 | -1.38% |
| 2026-02-19 | 10.71 | 10.98 | 9.98 | 10.12 | 339K | -5.51% |
| 2026-02-18 | 10.66 | 11.28 | 10.51 | 10.71 | 555K | -4.88% |
| 2026-02-17 | 11.25 | 11.26 | 11.25 | 11.26 | 5K | +0.09% |
| 2026-02-13 | 11.42 | 11.73 | 11.10 | 11.25 | 219K | -1.49% |
| 2026-02-12 | 12.02 | 12.23 | 11.00 | 11.42 | 323K | -5.15% |
| 2026-02-11 | 11.07 | 12.17 | 10.50 | 12.04 | 321K | +11.07% |
| 2026-02-10 | 10.75 | 11.20 | 10.49 | 10.84 | 335K | +1.50% |
| 2026-02-09 | 10.75 | 10.93 | 10.40 | 10.68 | 180K | -0.19% |
| 2026-02-06 | 10.50 | 11.55 | 10.21 | 10.70 | 521K | +5.42% |
| 2026-02-05 | 11.67 | 12.01 | 10.08 | 10.15 | 469K | -13.17% |
| 2026-02-04 | 11.73 | 11.86 | 11.29 | 11.69 | 222K | -1.60% |
| 2026-02-03 | 12.04 | 12.55 | 11.73 | 11.88 | 129K | -1.25% |
| 2026-02-02 | 11.71 | 12.33 | 11.63 | 12.03 | 154K | +2.65% |
| 2026-01-30 | 12.50 | 12.57 | 11.72 | 11.72 | 159K | -6.24% |
| 2026-01-29 | 12.80 | 13.28 | 12.33 | 12.50 | 253K | -3.70% |
| 2026-01-28 | 13.67 | 13.71 | 12.93 | 12.98 | 160K | -4.63% |
| 2026-01-27 | 12.63 | 13.99 | 12.55 | 13.61 | 320K | +8.45% |
| 2026-01-26 | 12.64 | 12.79 | 12.08 | 12.55 | 202K | -0.55% |
| 2026-01-24 | 11.18 | 12.67 | 10.88 | 12.62 | 418K | 0.00% |
| 2026-01-23 | 11.18 | 12.67 | 10.88 | 12.62 | 419K | +12.18% |
| 2026-01-22 | 11.43 | 11.58 | 11.24 | 11.25 | 164K | -1.23% |
| 2026-01-21 | 11.51 | 11.63 | 11.24 | 11.39 | 344K | -0.61% |
| 2026-01-20 | 11.39 | 11.68 | 11.28 | 11.46 | 300K | +0.39% |
| 2026-01-16 | 11.50 | 11.53 | 11.05 | 11.41 | 198K | -0.74% |
See BBOT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BBOT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare BBOT vs AGIO
See how BBOT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has BBOT stock performed recently?
BBOT declined -9.2% over the past year, below its 5-year annualized CAGR of -0.3%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is BBOT's all-time high price?
BridgeBio Oncology Therapeutics Inc. reached $14.87 on 2025-12-08. The 52-week high is $14.87. Current 1-year return of -9.2% places the stock further from historical peaks.
Where can I download BBOT historical price data?
This page provides BBOT daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2024-2026, downloadable in CSV format.